Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) has been given an average rating of "Buy" by the sixteen brokerages that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, twelve have assigned a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $25.07.
Several research firms have commented on PRVA. Truist Financial increased their price objective on shares of Privia Health Group from $24.00 to $27.00 and gave the company a "buy" rating in a report on Friday, November 8th. Barclays raised their target price on shares of Privia Health Group from $19.00 to $21.00 and gave the company an "equal weight" rating in a research note on Friday, November 8th. KeyCorp began coverage on shares of Privia Health Group in a report on Friday, October 11th. They issued an "overweight" rating and a $23.00 price target for the company. Royal Bank of Canada reissued an "outperform" rating and set a $28.00 target price on shares of Privia Health Group in a report on Wednesday, August 14th. Finally, Robert W. Baird raised their target price on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an "outperform" rating in a report on Monday, August 26th.
Check Out Our Latest Stock Report on Privia Health Group
Insiders Place Their Bets
In other news, CEO Parth Mehrotra sold 135,142 shares of the business's stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total value of $2,500,127.00. Following the sale, the chief executive officer now directly owns 247,771 shares of the company's stock, valued at approximately $4,583,763.50. The trade was a 35.29 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 14.20% of the stock is owned by insiders.
Institutional Investors Weigh In On Privia Health Group
Several large investors have recently added to or reduced their stakes in the business. FMR LLC grew its holdings in Privia Health Group by 1.5% during the 3rd quarter. FMR LLC now owns 18,169,043 shares of the company's stock worth $330,858,000 after acquiring an additional 271,645 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of Privia Health Group by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 11,400,035 shares of the company's stock valued at $223,327,000 after buying an additional 121,701 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Privia Health Group by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company's stock valued at $43,986,000 after buying an additional 23,178 shares in the last quarter. Millennium Management LLC boosted its holdings in shares of Privia Health Group by 2,994.2% in the 2nd quarter. Millennium Management LLC now owns 1,138,526 shares of the company's stock valued at $19,788,000 after buying an additional 1,101,730 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Privia Health Group by 18.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,118,619 shares of the company's stock valued at $19,441,000 after buying an additional 173,934 shares in the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.
Privia Health Group Trading Up 0.8 %
Privia Health Group stock traded up $0.16 during mid-day trading on Tuesday, hitting $21.11. The stock had a trading volume of 306,460 shares, compared to its average volume of 864,075. The firm has a market capitalization of $2.53 billion, a P/E ratio of 209.52, a P/E/G ratio of 5.29 and a beta of 0.76. The firm's 50 day moving average is $18.76 and its 200 day moving average is $18.51. Privia Health Group has a one year low of $15.92 and a one year high of $24.30.
Privia Health Group Company Profile
(
Get Free ReportPrivia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
See Also
Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.